Quarterly report pursuant to Section 13 or 15(d)

Stock based compensation, options and warrants

v3.19.1
Stock based compensation, options and warrants
3 Months Ended
Mar. 31, 2019
Share-based Payment Arrangement [Abstract]  
Stock based compensation, options and warrants
Note 9. Stock based compensation, options and warrants:

Stock based compensation:

The Company’s stock-based compensation expenses recognized during the three months ended March 31, 2019 and 2018, were attributable to selling, general and administrative expenses, which are included in the accompanying consolidated statements of operations.
 
The Company recognized total stock-based compensation expense during the three months ended March 31, 2019 and 2018, from the following categories:

   
Three Months Ended March 31,
 
   
2019
   
2018
 
Restricted stock awards under the Plan
 
$
176,544
   
$
766,949
 
Stock option awards under the Plan
   
58,498
     
116,994
 
    Total stock-based compensation
 
$
235,042
   
$
883,943
 
 
Restricted stock units:

A summary of the Company’s unvested restricted stock activity in the three months ended March 31, 2019 is presented here:
 
   
Number of Shares
   
Weighted Average Grant-Date
Fair Value
 
Unvested at January 1, 2018
   
95,939
   
$
12.49
 
Vested
   
(22,397
)
 
$
9.37
 
Forfeited
   
(40,000
)
 
$
16.82
 
Unvested at March 31, 2019
   
33,542
   
$
9.39
 
 
During the three months ended March 31, 2019, the Company did not grant restricted stock units.

During the three months ended March 31, 2019, forfeitures of restricted common stock totaled 40,000, which consisted of  shares forfeited due to the termination of two of the Company’s officers.

The fair value of restricted stock unit grants is measured based on their fair value on the date of grant and amortized over the vesting period of twenty-four months. As of March 31, 2019, there was approximately $0.3 million of unrecognized compensation cost related to unvested restricted stock units, which is expected to be recognized over a remaining weighted-average vesting period of approximately 4 months.

Stock incentive plan options:

A summary of activity under the Plan for the three months ended March 31, 2019 is presented below:
 
   
Shares Underlying Options
   
Weighted Average Exercise Price
   
Weighted Average Remaining Contractual
Term (Years)
   
Aggregate Intrinsic Value
 
Outstanding at January 1, 2019
   
62,000
   
$
15.71
     
9.2
   
$
-
 
Outstanding at March 31, 2019
   
62,000
   
$
15.71
     
9.0
   
$
-
 
                                 
Exercisable at March 31, 2019
   
62,000
   
$
15.71
     
9.0
   
$
-
 

Aggregate intrinsic value represents the total intrinsic value (the difference between the Company’s closing stock price on March 31, 2019 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders, had all option holders been able to, and in fact had, exercised their options on March 31, 2019.

As of March 31, 2019, there was no unrecognized stock-based compensation expense related to unvested options.
 
Other common stock purchase options and warrants:

Following is a summary of outstanding options and warrants that were issued outside of the Plan for the three months ended March 31, 2019:
 
   
Shares Underlying Options/Warrants
   
Weighted Average Exercise Price
   
Weighted Average Remaining Contractual
Term (Years)
   
Aggregate Intrinsic Value
 
Outstanding at January 1, 2019
   
1,671,113
   
$
39.47
     
2.0
   
$
-
 
Granted
   
1,908,144
   
$
1.94
     
5.2
   
$
2,537,832
 
Outstanding at March 31, 2019
   
3,579,257
   
$
19.46
     
3.6
   
$
2,537,832
 
                                 
Exercisable at March 31, 2019
   
3,579,257
   
$
19.46
     
5.2
   
$
2,537,832
 

The Company granted warrants to purchase 1,908,144 shares of its common stock with an exercise price of $1.94, in connection with its Senior Secured Promissory Notes issued on January 28, 2019. (See Note 7).

The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company’s closing stock price on March 31, 2019 and the exercise price, multiplied by the number of in-the-money options and warrants) that would have been received by the option and warrant holders, had all option and warrant holders been able to, and in fact had, exercised their options and warrants on March 31, 2019.